查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1629860

全球硬脂酸鎂市場 - 2024-2031

Global Magnesium Stearate Market - 2024-2031
出版日期: | 出版商: DataM Intelligence | 英文 201 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2023年全球硬脂酸鎂市場規模達5.3333億美元，預計2031年將達到8.5125億美元，2024-2031年預測期間複合年成長率為6.0%。

硬脂酸鎂是硬脂酸的鎂鹽，廣泛用作潤滑劑、抗結塊劑和脫模劑。它在藥品中的應用，特別是作為片劑黏合劑和包衣劑，佔其全球需求的很大一部分。此外，硬脂酸鎂在確保製造過程的一致性和品質方面的效用也有助於其不斷上升的市場佔有率。

由於硬脂酸鎂在藥品、化妝品和食品等各行業的使用量不斷增加，全球硬脂酸鎂市場正在快速成長。根據聯合國 (UN) 統計，到 2050 年，全球 65 歲及以上人口預計將加倍，達到 15 億。這種人口結構的變化將顯著增加藥品中硬脂酸鎂的需求，因為人口老化需要更多的藥物。

在製藥和化妝品行業強勁成長的推動下，亞太地區正成為硬脂酸鎂成長最快的市場。亞洲開發銀行（ADB）表示，隨著印度和中國等國家大力投資藥品生產，該地區的醫療保健支出預計將大幅增加。

印度品牌公平基金會(IBEF) 報告稱，2023 年印度藥品出口額超過250 億美元。創造了巨大的需求用於硬脂酸鎂等賦形劑。

動力學

技術進步與擴大應用

硬脂酸鎂生產技術的進步顯著提高了其品質並拓寬了其應用範圍。在製藥業，硬脂酸鎂可確保片劑的完整性和穩定性，改善藥物傳遞系統。最近的創新，例如微粉化硬脂酸鎂，提供卓越的性能和分散特性，滿足主要市場嚴格的監管要求。

在化妝品產業中，硬脂酸鎂廣泛用作爽身粉、眼影和口紅中的質感增強劑。根據 Cosmetics Europe 的數據，歐洲仍然是化妝品和個人護理產品的全球旗艦市場，2023 年零售價約為 950 億美元。食品和飲料。

品質標準意識不斷增強

美國食品藥物管理局(FDA)、歐洲藥品管理局(EMA) 和世界衛生組織(WHO) 等主要組織建立的監管框架在確保硬脂酸鎂產品的安全性和有效性方面發揮至關重要的作用。這些框架強制遵守嚴格的藥典標準，包括美國藥典 (USP) 和歐洲藥典 (EP) 制定的標準，迫使製造商創新和改進其生產流程。

遵守這些標準不僅可以保證產品質量，還可以創造競爭性的市場環境，激勵製造商提高營運效率和產品配方。因此，公司越來越注重滿足這些嚴格的指導方針，以確保其產品不僅符合監管要求，而且滿足消費者對更安全、更有效的藥用輔料不斷變化的需求。

供應鏈中斷和原料成本上漲

硬脂酸鎂主要源自鎂，鎂是從菱鎂礦或白雲石等礦物中提取的金屬。這些原料的價格因供應短缺或地緣政治緊張等因素而波動，這會顯著影響硬脂酸鎂生產的成本結構。作為藥品和食品加工中廣泛使用的輔料，原料價格的任何不穩定性都可能導致生產成本增加，影響整體市場動態。

此外，人們對食品添加劑的安全性越來越關注，這可能會導致未來監管更加嚴格。監管機構擴大審查添加劑的使用，以確保消費者安全，這可能給硬脂酸鎂市場帶來挑戰。然而，正在進行的研究和監管批准的建立預計將有效解決這些問題，有助於保持硬脂酸鎂在各種應用中提供的安全性和功能性優勢之間的平衡。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動力學

  • 影響因素
    • 促進要素
      • 技術進步與擴大應用
      • 品質標準意識不斷增強
    • 限制
      • 供應鏈中斷和原料成本上漲
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 俄烏戰爭影響分析
  • DMI 意見

第 6 章：按申請

  • 潤滑劑
  • 黏合劑和填料
  • 乳化劑
  • 穩定劑
  • 其他

第 7 章：最終用戶

  • 製藥
  • 食品及飲料
  • 個人護理
  • 塑膠
  • 其他

第 8 章：永續性分析

  • 環境分析
  • 經濟分析
  • 治理分析

第 9 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 10 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 11 章：公司簡介

  • Thermo Fisher Scientific
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • PT Halim Sakti Pratama
  • Parchem Fine & Specialty Chemicals
  • Nimbasia
  • Baerlocher GmbH
  • Valtris Specialty Chemicals
  • FACI SPA
  • Merck KGaA
  • Kirsch Pharma GmbH
  • James M. Brown Ltd

第 12 章：附錄

簡介目錄
Product Code: FB8915

Global Magnesium Stearate Market reached US$ 533.33 million in 2023 and is expected to reach US$ 851.25 million by 2031, growing with a CAGR of 6.0% during the forecast period 2024-2031.

Magnesium stearate, a magnesium salt of stearic acid, is extensively utilized as a lubricant, anti-caking agent and release agent. Its applications in pharmaceuticals, particularly as a tablet binder and coating agent, account for a significant portion of its global demand. Furthermore, magnesium stearate's utility in ensuring consistency and quality in manufacturing processes contributes to its rising market share.

The global magnesium stearate market is witnessing rapid growth, driven by its increasing use across various industries such as pharmaceuticals, cosmetics and food. According to the United Nations (UN), the global population aged 65 and above is expected to double by 2050, reaching 1.5 billion. This demographic shift will significantly increase the demand for magnesium stearate in pharmaceuticals, as aging populations require more medications.

Asia-Pacific is emerging as the fastest-growing market for magnesium stearate, driven by robust growth in the pharmaceutical and cosmetics industries. According to the Asian Development Bank (ADB), the region's healthcare expenditure is expected to rise significantly, with countries like India and China investing heavily in pharmaceutical production.

The India Brand Equity Foundation (IBEF) reports that India's pharmaceutical exports surpassed US$ 25 billion in 2023. The country exported US$ 2.43 billion worth of drugs and pharmaceuticals in April 2024 alone, up from US$ 2.26 billion in April 2023 creating substantial demand for excipients like magnesium stearate.

Dynamics

Technological Advancements and Expanding Applications

Technological advancements in magnesium stearate production have significantly enhanced its quality and broadened its application spectrum. In the pharmaceutical industry, magnesium stearate ensures tablet integrity and stability, improving drug delivery systems. Recent innovations, such as micronized magnesium stearate, offer superior performance and dispersion properties, meeting stringent regulatory requirements in key markets.

In the cosmetics industry, magnesium stearate is widely used as a texture-enhancing agent in face powders, eye shadows and lipsticks. According to Cosmetics Europe, Europe remains a global flagship market for cosmetics and personal care products, approximately valued at US$ 95 billion in retail sales price in 2023. The food industry also relies on magnesium stearate as an additive to prevent ingredient clumping, particularly in powdered foods and beverages.

Rising Awareness of Quality Standards

Regulatory frameworks established by key organizations such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA) and the World Health Organization (WHO) play a crucial role in ensuring the safety and effectiveness of magnesium stearate products. These frameworks enforce compliance with stringent pharmacopeial standards, including those set by US Pharmacopeia (USP) and the European Pharmacopoeia (EP), which compel manufacturers to innovate and refine their production processes.

Adherence to these standards not only guarantees product quality but also fosters a competitive market environment where manufacturers are incentivized to enhance their operational efficiencies and product formulations. As a result, companies are increasingly focusing on meeting these rigorous guidelines to ensure that their products not only comply with regulatory requirements but also meet the evolving demands of consumers for safer and more effective pharmaceutical excipients.

Supply Chain Disruptions and Rising Raw Material Costs

Magnesium stearate is primarily sourced from magnesium, a metal extracted from minerals such as magnesite or dolomite. The prices of these raw materials fluctuate due to factors like supply shortages or geopolitical tensions, which can significantly affect the cost structure of magnesium stearate production. As a widely used excipient in pharmaceuticals and food processing, any instability in raw material pricing can lead to increased production costs, impacting the overall market dynamics.

Additionally, there is growing concern regarding the safety of food additives, which may result in stricter regulations in the future. Regulatory bodies are increasingly scrutinizing the use of additives to ensure consumer safety, potentially posing challenges for the magnesium stearate market. However, ongoing research and the establishment of regulatory approvals are expected to address these concerns effectively, helping to maintain the balance between safety and the functional benefits that magnesium stearate provides in various applications.

Segment Analysis

The global magnesium stearate market is segmented based on application, end-user and region.

Increasing Demand from the Pharmaceutical Sector

The pharmaceutical industry is the largest consumer of magnesium stearate. This excipient plays a vital role in drug formulation, particularly due to its ability to enhance the compressibility and flowability of active pharmaceutical ingredients (APIs). As the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) projects that the biopharmaceutical market will exceed US$ 1.750-1.780 trillion by 2026, the demand for magnesium stearate is expected to rise significantly, reinforcing its status as a critical component in modern drug manufacturing.

Magnesium stearate serves multiple functions in pharmaceutical applications, primarily acting as a lubricant that reduces friction between particles during the manufacturing process. This property is essential for ensuring efficient production of tablets and capsules, as it prevents ingredients from sticking to machinery and promotes consistent dosing. Additionally, magnesium stearate aids in improving the flow properties of drug powders, which is crucial for handling and processing during production. Its indispensable role in enhancing the quality and efficacy of pharmaceuticals underscores its importance in the industry.

Geographical Penetration

Strong Consumer Awareness in North America

North America dominates the magnesium stearate market, largely due to its robust pharmaceutical and food processing industries. The U.S. Food and Drug Administration (FDA) plays a critical role in this sector by emphasizing the necessity for high-quality excipients, which compels domestic manufacturers to adhere to stringent compliance and quality standards. According to the Centers for Medicare & Medicaid Services, in the U.S. healthcare spending grew 4.1% in 2022, reaching US$ 4.5 trillion or US$ 13,493 per person, highlighting the substantial demand for magnesium stearate within these industries.

The focus on magnesium stearate's quality is further reinforced by the FDA's regulations, which require manufacturers to ensure that their excipients meet the standards set by US Pharmacopeia (USP) and National Formulary (NF). This regulatory oversight is crucial as it not only safeguards patient safety but also maintains the integrity of drug formulations. Consequently, manufacturers are increasingly investing in quality assurance processes to comply with these regulations, ensuring that magnesium stearate and other excipients are safe and effective for use in pharmaceutical applications.

Competitive Landscape

The major global players in the market include Thermo Fisher Scientific, PT Halim Sakti Pratama, Parchem Fine & Specialty Chemicals, Nimbasia, Baerlocher GmbH, Valtris Specialty Chemicals, FACI SPA, Merck KGaA, Kirsch Pharma GmbH and James M. Brown Ltd.

Sustainability Analysis

The magnesium stearate market is increasingly prioritizing sustainability as manufacturers adopt energy-efficient processes and explore biodegradable formulations. These initiatives are crucial for meeting global sustainability goals and responding to rising consumer demand for eco-friendly products. According to the Global Sustainability Council for Chemicals (GSCC), the shift towards sustainable practices is not just a trend but a necessary evolution in the industry, aligning with broader environmental objectives.

Leading companies in the magnesium stearate sector are focusing on innovative production methods that minimize environmental impact. This includes the use of renewable resources and the development of formulations that reduce reliance on non-biodegradable materials. As sustainability becomes a key factor in purchasing decisions, manufacturers recognize the importance of adapting to these changes to remain competitive and relevant in a market that increasingly values ecological responsibility.

Advanced Material Innovations in the Magnesium Stearate Market

Innovations in material science and production processes are significantly shaping the magnesium stearate market. One of the most notable innovations in the magnesium stearate market is the development of nano-formulations. The ultra-fine particles of magnesium stearate enhance the flowability and uniformity of powders used in tablet and capsule manufacturing. The use of nano-sized magnesium stearate improves the consistency of active pharmaceutical ingredients (APIs) in solid dosage forms, ensuring better performance and drug release characteristics.

Similarly, innovations in drug delivery systems, such as controlled and sustained-release formulations, are driving the demand for specialized grades of magnesium stearate. Advanced drug formulations that require precise control over the release rate of the active ingredient benefit from the lubrication properties of magnesium stearate. New formulations are being developed to improve their compatibility with different types of APIs, including those that are poorly soluble in water, to enhance the bioavailability and therapeutic effectiveness of drugs.

By Application

  • Lubricants
  • Binders and Fillers
  • Emulsifiers
  • Stabilizers
  • Others

By End-User

  • Pharmaceutical
  • Food & Beverage
  • Personal Care
  • Plastics
  • Other

By Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In August 2023, Peter Greven, a leading producer of oleochemical additives and auxiliary products, made a strategic move to strengthen its foothold in the Chinese market. The company announced the purchase of a new plant for the production of magnesium stearate, a move that is expected to enhance its position in China across several product categories.
  • In September 2023, Elite Chemicals, a renowned pharmaceutical company, announced the launch of a new line of magnesium stearate products specifically designed for the food industry. These products are gluten-free and non-GMO, addressing the evolving needs of the food sector, where clean labels and healthy ingredients are becoming increasingly important.
  • On August 2, 2022, SK Capital Partners, a private investment firm based in New York with a focus on specialty chemicals, materials and pharmaceuticals, announced the completion of its acquisition of Valtris Specialty Chemicals from H.I.G. Capital. The acquisition strengthens SK Capital's portfolio in the specialty chemicals sector and is expected to drive further innovation and market expansion for Valtris, particularly in the development of key chemical products such as magnesium stearate.

Why Purchase the Report?

  • To visualize the global magnesium stearate market segmentation based on application, user and region.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points at the magnesium stearate market level for all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global magnesium stearate market report would provide approximately 54 tables, 46 figures and 201 pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Application
  • 3.2. Snippet by End-User
  • 3.3. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Technological Advancements and Expanding Applications
      • 4.1.1.2. Rising Awareness of Quality Standards
    • 4.1.2. Restraints
      • 4.1.2.1. Supply Chain Disruptions and Rising Raw Material Costs
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. By Application

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 6.1.2. Market Attractiveness Index, By Application
  • 6.2. Lubricants*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Binders and Fillers
  • 6.4. Emulsifiers
  • 6.5. Stabilizers
  • 6.6. Others

7. By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.1.2. Market Attractiveness Index, By End-User
  • 7.2. Pharmaceutical*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Food & Beverage
  • 7.4. Personal Care
  • 7.5. Plastics
  • 7.6. Other

8. Sustainability Analysis

  • 8.1. Environmental Analysis
  • 8.2. Economic Analysis
  • 8.3. Governance Analysis

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. US
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. UK
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Thermo Fisher Scientific*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. PT Halim Sakti Pratama
  • 11.3. Parchem Fine & Specialty Chemicals
  • 11.4. Nimbasia
  • 11.5. Baerlocher GmbH
  • 11.6. Valtris Specialty Chemicals
  • 11.7. FACI SPA
  • 11.8. Merck KGaA
  • 11.9. Kirsch Pharma GmbH
  • 11.10. James M. Brown Ltd

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us